Total awarded
€35.37M
Award notices won
16
Lots won
35
Last award
Jun 24, 2024
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0015 / okrelizumab infusioonilahuse kontsentraat 1mg | 33652000 | supplies | €5.00M | - | EST | price / 100 |
LOT-0017 / Pertuzumab + trastuzumab | 33600000 | supplies | €5.00M | - | EST | price / 100 |
LOT-0013 / Atezolisumab | 33600000 | supplies | €4.50M | - | EST | price / 100 |
LOT-0017 / L01FF05 Atesolizumab | 33600000 | supplies | €4.09M | - | EST | price / 100 |
LOT-0005 / Trastuzumabemtansiin | 33600000 | supplies | €4.00M | - | EST | price / 100 |
LOT-0000 / Atesolizumab s.c. | 33600000 | supplies | €1.40M | - | EST | price / 100 |
LOT-0020 / L01XY02 Pertuzumab +trastuzumab | 33600000 | supplies | €1.21M | - | EST | price / 100 |
LOT-0019 / L01FF05 Atesolizumab | 33600000 | supplies | €1.20M | - | EST | price / 100 |
LOT-0012 / L04AA36 Ocrelizumab | 33600000 | supplies | €1.20M | - | EST | price / 100 |
LOT-0013 / L01FX14 Polatuzumabvedotiin | 33600000 | supplies | €1.02M | - | EST | price / 100 |
LOT-0004 / Pertuzumab | 33600000 | supplies | €1.00M | - | EST | price / 100 |
LOT-0006 / Obinutuzumab | 33600000 | supplies | €1.00M | - | EST | price / 100 |
LOT-0003 / Pertuzumab + trastuzumab | 33600000 | supplies | €838,807 | - | EST | price / 100 |
LOT-0019 / Okrelizumab | 33600000 | supplies | €800,000 | - | EST | price / 100 |
LOT-0003 / beetaepoetiin süstelahus süstlis 1TÜ | 33621000 | supplies | €600,000 | - | EST | price / 100 |
LOT-0002 / Polatuzumabvedotiin | 33600000 | supplies | €500,000 | - | EST | price / 100 |
LOT-0003 / Atezolisumab | 33600000 | supplies | €435,311 | - | EST | price / 100 |
LOT-0018 / L01FF05 Atesolizumab | 33600000 | supplies | €421,403 | - | EST | price / 100 |
LOT-0014 / L04AC07 Tocilizumab | 33600000 | supplies | €276,185 | - | EST | price / 100 |
LOT-0015 / L04AC07 Tocilizumab | 33600000 | supplies | €118,365 | - | EST | price / 100 |
LOT-0003 / Okrelizumab | 33600000 | supplies | €108,000 | - | EST | price / 100 |
LOT-0001 / Atezolisumab | 33600000 | supplies | €97,247 | - | EST | price / 100 |
LOT-0004 / metoksüpolüetüleenglükool-beetaepoetiin süstelahus süstlis 1mcg | 33621000 | supplies | €80,000 | - | EST | price / 100 |
LOT-0019 / L01XY02 Pertuzumab +trastuzumab | 33600000 | supplies | €76,070 | - | EST | price / 100 |
LOT-0008 / mükofenoolhape kõvakapsel või tablett 1mg | 33652000 | supplies | €69,000 | - | EST | price / 100 |
LOT-0001 / Atezolisumab | 33600000 | supplies | €64,831 | - | EST | price / 100 |
LOT-0009 / S01LA09 Faricimab | 33690000 | supplies | €62,640 | - | EST | price / 100 |
LOT-0014 / L01FX14 Polatuzumabvedotiin | 33600000 | supplies | €54,600 | - | EST | price / 100 |
LOT-0003 / Faritsimab | 33600000 | supplies | €50,000 | - | EST | price / 100 |
LOT-0005 / Polatuzumabvedotiin | 33600000 | supplies | €23,800 | - | EST | price / 100 |
LOT-0049 / L04AA06 Mükofenoolhape | 33652000 | supplies | €21,560 | - | EST | price / 100 |
LOT-0012 / L04AC07 Tocilizumab | 33600000 | supplies | €16,926 | - | EST | price / 100 |
LOT-0011 / L04AC07 Tocilizumab | 33600000 | supplies | €15,798 | - | EST | price / 100 |
LOT-0013 / L04AC07 Tocilizumab | 33600000 | supplies | €11,284 | - | EST | price / 100 |
LOT-0026 / Faritsimab | 33600000 | supplies | €4,300 | - | EST | price / 100 |
Award tenders
| Tender | Buyer | Publication date | Procedure | Contract nature | Awarded to contractor | Lots won |
|---|---|---|---|---|---|---|
| Immunosupressantide ja immunostimulaatorite ostmine 374287-2024 | Aktsiaselts Lääne-Tallinna Keskhaigla | Jun 24, 2024 | open | supplies | €17.83M | 2 |
| Kasvajavastased ja immunomoduleerivad ained 354223-2024 | Aktsiaselts Ida-Tallinna Keskhaigla | Jun 14, 2024 | open | supplies | €1.56M | 1 |
| Atesolizumab s.c. 330279-2024 | Aktsiaselts Ida-Tallinna Keskhaigla | Jun 05, 2024 | neg-wo-call | supplies | €1.40M | 1 |
| Bioloogiliste ravimite ostmine 317668-2024 | sihtasutus Tartu Ülikooli Kliinikum | May 29, 2024 | open | supplies | €7.14M | 5 |
| Haiglaravimid - mai 2024 313656-2024 | sihtasutus Põhja-Eesti Regionaalhaigla | May 28, 2024 | restricted | supplies | €104,150 | 1 |
| Haiglaravimid - aprill 2024 266858-2024 | sihtasutus Põhja-Eesti Regionaalhaigla | May 06, 2024 | restricted | supplies | €494,175 | 1 |
| Antineoplastilised ravimid 207270-2024 | sihtasutus Tartu Ülikooli Kliinikum | Apr 09, 2024 | open | supplies | €9.94M | 5 |
| Monoklonaalsed antikehad, immuunosupressandid, teised astmavastased ained süsteemseks kasutamiseks, teised dermatoloogilised preparaadid 2 196031-2024 | sihtasutus Põhja-Eesti Regionaalhaigla | Apr 03, 2024 | open | supplies | €7.75M | 2 |
| Haiglaravimid - jaanuar 2024 81419-2024 | sihtasutus Põhja-Eesti Regionaalhaigla | Feb 07, 2024 | restricted | supplies | €698,353 | 2 |
| Verejooksu tõkestavad ja aneemiavastased ravimid KORDUSHANGE 77771-2024 | Aktsiaselts Lääne-Tallinna Keskhaigla | Feb 06, 2024 | neg-wo-call | supplies | €680,000 | 2 |
| Monoklonaalsed antikehad, immuunosupressandid, teised astmavastased ained süsteemseks kasutamiseks, teised dermatoloogilised preparaadid 72398-2024 | sihtasutus Põhja-Eesti Regionaalhaigla | Feb 02, 2024 | open | supplies | €45.05M | 6 |
| Antineoplastilised ja immuunosupresseerivad ravimid 731045-2023 | sihtasutus Tartu Ülikooli Kliinikum | Dec 01, 2023 | open | supplies | €4.48M | 1 |
| Silmakirurgias kasutatavad ravimid/lahused 639620-2023 | sihtasutus Tartu Ülikooli Kliinikum | Oct 20, 2023 | open | supplies | €421,555 | 1 |
| Meeleelundite ravimid (S-grupp) ja oftalmoloogilised lahused 530468-2023 | Aktsiaselts Ida-Tallinna Keskhaigla | Sep 01, 2023 | open | supplies | €1.31M | 1 |
| Ravimid tsefoksitiin, ipilimumab, okrelizumab ja immuunoglobuliin intravaskulaarseks kasutamiseks 429703-2023 | sihtasutus Põhja-Eesti Regionaalhaigla | Jul 14, 2023 | restricted | supplies | €1.51M | 1 |
| Tervishoiuteenuste osutamisel kasutatavad ravimid 422842-2023 | sihtasutus Tartu Ülikooli Kliinikum | Jul 12, 2023 | open | supplies | €13.15M | 3 |
Company details
Identifiers
11124024
Countries
EST
Cities
Tallinn
Post codes
11415
Emails
CPV codes
Listed
false
About this contractor
Roche Eesti Osaühing is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.